Elisabeth H Villavicencio, MD, PhD

Elisabeth H Villavicencio, MD, PhD


On staff since July 2008

Children's Title: Medical Director, Hematology/Oncology Service

Academic Title: Clinical Associate Professor

"Patients and families deserve exceptional care around the clock. Our Acute Care Oncology team is at the hospital every night, ensuring that patients with cancer, blood disorders, and hematopoietic stem cell transplants have continuous access to in-person subspecialty attending care."

  • Biography

    Dr. Villavicencio is an attending physician in the Cancer and Blood Disorders Center at Seattle Children’s Hospital and a clinical associate professor at the University of Washington School of Medicine. She founded the overnight Acute Care Oncology overnight attending team and continues to serve as its Medical Director. Her interests include subspecialty hospital medicine, attending co-management, physician wellness, and resident teaching.

  • Patient Testimonials

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    Provider of the Year award nominee Cancer Care Unit, Seattle Children's Hospital 2019
    Resident Teaching Evaluations, highest possible scores Seattle Children's Hospital 2018 - 2020
    Chair’s Commendation for Outstanding Mentoring Seattle Children's Hospital 2015
    Chair’s Commendation for Outstanding Resident Teaching Seattle Children's Hospital 2015 - 2016
    Chair’s Commendation for Outstanding Mentoring Seattle Children's Hospital 2012
  • Publications

    Other Publications

    • Lee MJ, Hatton BA, Villavicencio EH, Khanna PC, Friedman SD, Ditzler S, Pullar B, Robison K, White KF, Tunkey C, LeBlanc M, Randolph-Habecker J, Knoblaugh SE, Hansen S, Richards A, Wainwright BJ, McGovern K, Olson JM
      Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model.
      22550175 Proceedings of the National Academy of Sciences of the United States of America, 2012 May 15 : 109(20)7859-64 PMCID:PMC3356655
    • Giussani C, Poliakov A, Ferri RT, Plawner LL, Browd SR, Shaw DW, Filardi TZ, Hoeppner C, Geyer JR, Olson JM, Douglas JG, Villavicencio EH, Ellenbogen RG, Ojemann JG
      DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma.
      20363335 NeuroImage, 2010 Aug 1 : 217-23
    • Hatton BA, Villavicencio EH, Tsuchiya KD, Pritchard JI, Ditzler S, Pullar B, Hansen S, Knoblaugh SE, Lee D, Eberhart CG, Hallahan AR, Olson JM
      The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.
      18339857 Cancer research, 2008 Mar 15 : 1768-76
    • Villavicencio EH, Yoon JW, Frank DJ, Füchtbauer EM, Walterhouse DO, Iannaccone PM
      Cooperative E-box regulation of human GLI1 by TWIST and USF.
      11948912 Genesis (New York, N.Y. : 2000), 2002 April : 247-58
  • Presentations

    Presentation Title Event Location Date
    Respiratory Escalations of Care in Pediatric Oncology and Bone Marrow Transplant, Wilkes J, Villavicencio E, Siegfried C, Heissenbuttel A, Garson G, Barry D, Masse E, Roberts J Pediatric Onco-Critical Care Symposium (POCCS 2020) St. Jude 2021
    Reducing Intravenous (IV) Acetaminophen Use for Pediatric Hematology/Oncology/BMT Patients (SCH), Wilkes J, Gurunathan A, Villavicencio E, Riotto N, Mauriello N, Garson G, Stoer M, Chan A, and Ahl C Poster presentation for Certificate Program in Patient Quality and Safety: SCH and UW Medicine Virtual 2021
    Sleep Health, Expectations and Evaluations for Physicians (SHEEP): A QI-based approach to improving attending sleep, Powell W, Chen M, Alberda E, Villavicencio E, Taylor J, Garrison M, and Tieder J Poster at Pediatric Academic Sciences (PAS) Conference Toronto, Ontario 2018
    Using Peer Coaching to Reduce Inappropriate or Duplicate Lab Testing, O’Callaghan J, Beck K, Cartin B, Tamura G, Hunt S, Villavicencio E, Bruener C, Tieder J Poster at Society of Hospital Medicine Conference Las Vegas, NV 2017
    Effect of Early ICU Transfer in Pediatric Oncology Patients with Hypotension, Wenger J, Villavicencio E, Watson S, Kroon L, Geyer R, Zimmerman J, and Roberts J Poster at Society of Critical Care Medicine Conference Orlando, FL 2016
    Hospitalist notification and RRT Documentation Associated with Fewer Severe Clinical Deteriorations (SCDs) on Cancer Care Unit, Aller S, Babcock J, Faucette K, Murphy J, and Villavicencio E Poster at Pediatric Hospital Medicine Conference Chicago, IL 2016
  • Research Funding

    Grant Title Grantor Amount Award Date
    NIH K12 Career Development in Pediatric and Medical Oncology Award National Institute of Health 2008 - 2009
    St. Baldrick’s Foundation Career Development Award St. Baldrick's Foundation 2008 - 2009


Clinical Interests

Inpatient care of children and young adults with cancer, blood diseases, and hematopoietic stem cell transplants 

Research Description

Dr. Villavicencio’s primary focus is on hospital care of patients with cancer, blood disorders, and hematopoietic stem cell transplants. She is engaged in a variety of quality and safety projects. 

Research Focus Area

BMT Hospital Medicine, Pediatric Hematology / Oncology